Power3 Medical Products, Inc. (PWRM.OB)
Power3 Medical Products, Inc. specializes in the early detection of breast cancer, to improve the survival rates and quality of life for women with the disease. According to the American Cancer Society, when breast cancer is confined to the breast, the five-year survival rate is close to 100%. Unfortunately, the standard of diagnosis for breast cancer is self-examination from age 20 and annual mammograms from age 40. By the time a cancer is detected by either method, the woman may have had the disease for six to ten years, with a significant risk of serious consequences including mortality.
PWRM uses its Proteomic-based platform to analyze breast cancer at the protein level. To date, they have identified over 120 distinct biomarkers relating to breast cancer. In collaboration with a major research institute in Houston Texas, the Company has developed the Early Detection Breast Cancer Test, BC-SeraPro™. This test indicates, years prior to mammography, whether the patient has an early indication for breast cancer and if they require more testing or treatment. Power3 believes the BC-SeraPro Test™ will become the standard precursor to the mammogram.
In 2003, the breast cancer diagnostic market totaled $7 billion, which included $4.2 billion in mammograms and most of the remaining $2.8 billion in biopsy procedures.
The global mammogram market is estimated at approximately $10 billion by the World Health Organization(WHO) and is growing especially in Asia where the incidences of breast cancer occur more frequently and at a younger age.
Breast cancer is the second leading cause of cancer deaths in women today.
As a New technology for early detection, minimally-invasive BC-SeraPro™ Test from Power3 should participate favorably in the aforementioned mammogram market and has the potential to capture a significant portion of the pre-mammography early detection market.
Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease).
For more information about Power3 Medical Products, Inc. please visit http://www.power3medical.com
National Health Partners, Inc. (NHPR.OB)
The delivery of health care services is the most visible part of any health care system, both to users and the general public.
National Health Partners, Inc. (National Health) is a national healthcare savings organization that provides discount healthcare membership programs to uninsured and underinsured people through a national healthcare savings network called “CARExpress.”
NHPR previously reported the recent signing of two new significant marketing agreements. These two clients provide very different opportunities and continue to expand the reach of CARExpress into new marketplaces.
By launching their own unique internet marketing program, the first group should be able to provide a widespread push into the on-line market to produce an excellent volume of new CARExpress sales into the pipeline.
In addition, the second group offers a reach into the wholesale marketplace where CARExpress will be wrapped into other programs to enhance the value of the overall package to the consumer. We would consider this non-traditional business and a great opportunity to expand our reach as well as recognition of the CARExpress program nationwide.
"I am very excited about the new opportunities that these two new clients provide to CARExpress. In addition to the new campaign that was launched just a few weeks ago, all of these new client opportunities will offer a sharp increase in CARExpress memberships and have a major impact on our overall sales for 2011," stated David M. Daniels, National Health Partners' President and CEO.
US health care expenditures totaled $2.2 trillion in 2006. According to Health Affairs, $7,498 be spent on every woman, man and child in the United States in 2007, 20 percent of all spending. Costs are projected to increase to $12,782 by 2016.
CARExpress is one of the largest networks of hospitals, doctors, dentists, pharmacists and other healthcare providers in the country and is comprised of over 1,000,000 medical professionals that belong to such PPOs as CareMark and Aetna. The company’s primary target customer group is the 47 million Americans who have no health insurance of any kind. The company’s secondary target customer group includes the millions of Americans who lack complete health insurance coverage.
For more information about National Health Partners, Inc. please visit http://www.nationalhealthpartners.com
Evergreen Energy, Inc (NYSE:EEE) announced Thomas H. Stoner, Jr. will resign as CEO effective July 1, 2011. Stoner will remain a member of the board of directors.
Evergreen Energy Inc. operates as a cleaner coal technology, energy production, and environmental solutions company in the United States. It operates two clean energy business units that own two proprietary technologies: K-Fuel, and the GreenCert suite of software and services.
AAR Corp. (NYSE:AIR) and Unison Industries jointly reported from the Paris Air Show that they have entered into an exclusive worldwide aftermarket distribution agreement for Unison Industries' electrical components, sensors, and systems for aircraft and industrial uses. The agreement is valued at more than $600 million dollars over a 10-year term.
AAR CORP. provides products and services for the aviation, government, and defense markets worldwide. The company?s Aviation Supply Chain segment engages in the purchase and sale of new, overhauled, and repaired engine and airframe parts and components for airline customers.
Permian Basin Royalty Trust (NYSE:PBT) declared a cash distribution to the holders of its units of beneficial interest of $.143921 per unit, payable on July 15, 2011, to unit holders of record on June 30, 2011. Permian's cash distribution history, current and prior year financial reports and tax information booklets, a link to filings made with the Securities and Exchange Commission and more can be found on its website at http://www.pbt-permianbasintrust.com/.
Permian Basin Royalty Trust owns overriding royalty rights in mineral properties in the United States. It holds a 75% net overriding royalty interest in the Waddell Ranch Properties located in Crane County, Texas; and a 95% net overriding royalty interest in the Texas Royalty Properties in Texas.
CRWESelect, a stock highlight publication is pleased to alert investors of stocks on the move.
Sign Up for our Free Stock Newsletter at http://www.crweselect.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWESelect.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer( http://crweselect.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWESelect.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock.Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received 3,000,000 shares of (144) restricted common stock from the company and 3,000,000 shares of free trading shares from a third party (PIERRE BESUCHET) for six months of advertisement services for National Health Partners Inc. (NHPR.OB). Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).